Spectra Intelligence Research Reports

Title	Published	Price
Indian Generics, 2008-2012: The Growing Threat to Westernised Markets By: Spectra Intelligence Indian pharmaceutical companies are grabbing headlines on an almost daily basis and are increasingly carving out market shares for themselves in the US and many other markets around the world. Several leading Indian pharmaceutical companies \| more...	1/1/2008	$3,120.00
The World Market for Gynaecology, 2007-2017 By: Spectra Intelligence Spectra's World Market for Gynaecology, 2007-2017 provides a unique assessment of current developments and prospective factors that will shape the global female health market over the next decade. This unrivalled, in-depth market research study commissioned \| more...	9/1/2007	$6,400.00
The Global Market for Antimicrobials and Antifungals: Challenging Resistance to 2016 By: Spectra Intelligence Antibiotic resistance is a significant problem which is negatively impacting prescribing patterns, consequently reducing antibiotic usage. The total worldwide market for antibiotics and antifungals was US$25 billion in 2005, but is predicted to fall to \| more...	12/1/2006	$3,120.00
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success By: Spectra Intelligence The stakes are high in the global oncology market, currently estimated at US$42 billion. Hundreds of novel and next-generation anticancer products are in research and development; however, not all are destined for market success and \| more...	11/1/2006	$3,120.00
Pharmaceutical Parallel Trade in the United Kingdom, 2000-2006: Market Insights and Trends in a Primary Import Destination By: Spectra Intelligence The UK is the top destination for parallel imported drugs. Approximately 20% of all National Health Service (NHS) dispensed drugs are parallel imports and the market is estimated to be valued at over £1 billion \| more...	8/1/2006	$1,350.00
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines and Commercial Opportunities By: Spectra Intelligence In a market currently valued around US$42 billion, cancer chemotherapies are on course for staggering growth potential and may revolutionize cancer treatments over the next 10 years according to Spectra's expert cancer report. "The chemotherapy \| more...	4/1/2006	$3,700.00
The World Market for Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry By: Spectra Intelligence The sexual disorder pharmacotherapy market is dominated by drugs indicated for erectile dysfunction which commands an estimated 78% of the total sexual disorder market valued at US$3 billion. Significant market opportunities are evident for the \| more...	1/1/2006	$2,145.00
The Global Market for Hormonal Contraceptives and Infertility Drugs, 2005-2012 By: Spectra Intelligence Drugs in reproductive medicine are evolving into highly sophisticated products with multifunctional pharmacological properties and clinical utilities. Novel contraceptive formulations with low side-effect profiles are providing women with flexible birth-control and menstrual management options whilst \| more...	1/1/2006	$2,145.00
Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets to 2012 and Beyond - Volume Edition By: Spectra Intelligence In a market currently valued at US$36 billion, pharmacotherapies for conditions such as sleep disorders, addictions, depression, infertility, sexual disorders, and chronological ageing, are forecast to triple in value to over US$100 billion by 2020. \| more...	1/1/2006	$8,900.00
The Global Market for Sleep-Wake Disorders, 2005-2012 Trends, Opportunities, and Insights in a High-Value CNS Therapy Area By: Spectra Intelligence The market for sleep-wake disorders is expanding based on new indications and novel drugs which offer efficacious sleep solutions and wake-promoting effects while limiting adverse side effects that are associated with conventional drugs. In a \| more...	12/1/2005	$2,145.00
The World Market for Addiction Disorders, 2005-2012: New Horizons in High-Profile Dependency Markets By: Spectra Intelligence Examines the market for addiction pharmacotherapies currently estimated at US$2 billion but forecast to increase 41% CAGR to US$2.9 billion by 2012. Drivers of growth include increasing global prevalence of alcohol, narcotic, and nicotine dependencies \| more...	12/1/2005	$2,145.00
The Global Image Dermatology Drug Market, 2005-2012: High-Growth Opportunities in Aesthetic Medicine By: Spectra Intelligence Examines the global market for aesthetic dermatologicals and specialty physician-dispensed drugs to treat conditions associated with deficits in physical image and form. Drugs such as botulinum toxins, retinoids, acid peels, 5-alpha reductase and lipase inhibitors \| more...	11/1/2005	$3,700.00
Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012 By: Spectra Intelligence This report examines the global mood disorder sector and highlights the converging market stimulators and inhibitors that may lead to a market decline from an estimated US$17.4 billion in 2005 to US$15 billion in 2012. \| more...	11/1/2005	$3,700.00
Title	Published	Price

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2008, All Rights Reserved, MarketResearch.com
10/7/2008 - 1